Since OCN can activate the cellular survival signaling molecule AKT (Liu et al., 2017), we thus explored whether OCN can reverse dopaminergic neuronal loss in PD models through the AKT/GSK3β signaling pathway. This evidence concerns the gene AKT1 and Parkinson disease.